Results 41 to 50 of about 19,107 (138)
, 2002 Anticoagulant therapy is highly effective and prevents death in more than 95% of patients who have suffered pulmonary embolism following deep vein thrombosis. Inferior vena caval filters provide an alternative to full anticoagulation in those patients at
Wong, K. C. +3 more
core
Right Cardiac Intracavitary Metastases from a Primary Intracranial Myxofibrosarcoma
, 2016 Primary intracranial myxofibrosarcoma is exceedingly rare, with less than 10 cases published. We present a case of a 23-year-old man with previous history of a primary low grade myxofibrosarcoma of the left parietal-occipital convexity resected in March ...
Mafra, M +3 more
core +1 more source
Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021
, 2023 Purpose Interventional procedures have become a mainstay in the therapy of acute limb ischemia caused by embolism or arterial thrombosis. Treatment options include pharmacological thrombolysis (PT) and mechanical thrombectomy (MT).
Alexander M. König +7 more
core +1 more source
Genome Aging in Women: Hematopoietic Loss of X Chromosome as An Exemplar
Aging Cell, Volume 25, Issue 11, November 2026.As studies at the intersection of genetics and aging are rapidly advancing, genome aging provides a novel mechanism by which aging phenotypes occur. In this Review, the authors examine the rise, expansion, and the consequences of X chromosome loss in female blood cells.
Xihan Guo, Xueqin Dai
wiley +1 more source
Alimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1219-1233, November 2026.Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala +13 more
wiley +1 more source
European Journal of Clinical Investigation, Volume 56, Issue 11, November 2026.The ETNA‐AF‐Europe 4‐year follow‐up sub‐analysis reaffirms the effectiveness and safety of adherent label‐recommended doses of edoxaban in patients with AF with varying degrees of renal impairment. Low number of patients and events of ¶stroke (n = 2) and †ICH (n = 1) may warrant results to be interpreted with caution.
Raffaele De Caterina +6 more
wiley +1 more source
Post hospital discharge thrombosis in patients with COVID-19
, 2021 Background : Coronavirus disease 2019 (COVID-19) is associated with a high incidence of thrombotic events during hospitalization, however, the need for postdischarge thromboprophylaxis remains unclear.
Zhao, Wei +5 more
core +1 more source
Fundamental &Clinical Pharmacology, Volume 40, Issue 6, November 2026.ABSTRACT Background Direct oral anticoagulants (DOAC) have become standard therapy for thrombosis prevention since 2008. Meta‐analyses (MAs) of randomized controlled trials (RCT) are considered high‐level evidence supporting clinical guidelines. However, methodological biases may yield false‐positive findings, particularly through inadequate hypothesis
Quentin Remy +4 more
wiley +1 more source
, 2016 CI, confidence interval; r VTE, recurrent venous thromboembolism; MCRB, major or clinically relevant bleeding; VKA, vitamin K antagonists; HR, hazard ratio; D, Dirichlet distribution applying to 2 or 3 linked probabilities with the parameter ...
J. Stevanović (3238986) +5 more
core +1 more source
Transfusion, Volume 66, Issue 11, Page 2101-2115, November 2026.Abstract Study Question To describe the blood product utilization during neonatal and pediatric extracorporeal membrane oxygenation (ECMO) and to determine whether its usage correlates with clinical outcomes of bleeding, thrombosis or mortality. Design Prospective observational study of neonatal and pediatric ECMO patients from September 2016, until ...
Rebecca Barton +15 more
wiley +1 more source